Injective (INJ) experienced a notable price increase exceeding 12% driven by the approval of the IIP-619 governance proposal which upgrades its MultiVM EVM architecture. Concurrently, Pineapple Financial (DAT) has accumulated 7% of INJ’s total supply, reflecting renewed institutional interest. Despite these positive developments and steady on-chain activity, INJ remains over 90% below its all-time high, facing challenges from broader altcoin market sentiment.